Cell and gene therapies offer treatment, and sometimes cures, for patients with serious, often rare, and never-before-addressed diseases. And many more have become available in recent years—more than 75 launched worldwide in 2019, and 96 new ones were on track for the end of 2020.
To read the article, see “A call to action: Opportunities and challenges for CGTs in Europe,” January 19, 2021.